Shionogi & Co., Ltd.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 17941
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 131130
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 22116
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1580
 
  
 
C07K PEPTIDES 15121
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 841
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 862
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7199

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0369,509 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYSep 07, 17Dec 28, 17[A61K, C07D]
2017/0297,999 METHOD FOR PRODUCING TRIPHENYLBUTENE DERIVATIVESep 15, 15Oct 19, 17[C07C]
2017/0268,034 METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITYJun 01, 17Sep 21, 17[C12Q, G01N]
2017/0253,607 LONG-ACTING HIV PROTEASE INHIBITORSep 10, 15Sep 07, 17[C07D]
2017/0066,754 ANTIVIRAL AGENTNov 18, 16Mar 09, 17[C07D]
2016/0331,688 SUSTAINED RELEASE FORMULATIONJan 30, 15Nov 17, 16[A61K]
2015/0361,093 HIV REPLICATION INHIBITORJan 30, 14Dec 17, 15[C07D]
2015/0216,804 PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVESMay 13, 13Aug 06, 15[A61K]
2014/0072,557 MEDICINAL AGENT FOR SUPPRESSING MALIGNANT TUMOR METASTASISFeb 27, 12Mar 13, 14[A61K]
2004/0229,909 Antiviral agentJan 30, 04Nov 18, 04[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902732 Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the sameSep 09, 16Feb 27, 18[A61K, C07D, C07C]
9890119 Indole and azaindole derivative having AMPK-activating activityFeb 26, 14Feb 13, 18[A61K, C07H, C07D]
9890164 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulatorsSep 18, 15Feb 13, 18[C07D]
9815835 Substituted polycyclic carbamolypyridone derivativeAug 31, 16Nov 14, 17[A61K, C07D, A61P]
9802959 Method of producing (4R,12aS)-7,9-dihalo-4-methyl-3,4,12,12a-tetrahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-dionesMar 28, 17Oct 31, 17[C07D]
9770695 Emulsion preparation device and emulsion preparation methodMar 04, 13Sep 26, 17[B01F]
9758513 Dihydrooxazine or oxazepine derivatives having BACE1 inhibitory activitySep 21, 16Sep 12, 17[C07D]
9758515 Substituted polycyclic carbamoyl pyridone derivative prodrugDec 05, 14Sep 12, 17[A61K, C07F, C07D]
9732060 Aminotriazine derivative and pharmaceutical composition comprising the sameJun 13, 14Aug 15, 17[A61K, C07D, A61P]
9725442 Heterocyclic derivative having PGD2 receptor antagonist activityOct 24, 12Aug 08, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0267,693 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 18, 17Sep 21, 17[A61K, C07D]
2017/0260,203 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 18, 17Sep 14, 17[A61K, C07D]
2017/0253,616 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMay 17, 17Sep 07, 17[A61K, C07D]
2017/0224,694 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 27, 17Aug 10, 17[A61K]
2017/0224,695 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 27, 17Aug 10, 17[A61K]
2017/0209,454 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedApr 10, 17Jul 27, 17[A61K]
2017/0145,033 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedFeb 08, 17May 25, 17[C07D]
2017/0073,337 DIHYDROTHIAZINE AND DIHYDROOXAZINE DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITYAbandonedApr 10, 15Mar 16, 17[C07D]
2017/0029,438 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedOct 11, 16Feb 02, 17[A61K, C07D]
2016/0304,535 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedJun 29, 16Oct 20, 16[C07D]
2016/0207,939 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITYAbandonedMar 31, 16Jul 21, 16[C07D]
2016/0137,666 SUBSTITUTED CYCLOPENTA[4,5]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINES AS HIV INTEGRASE INHIBITORSAbandonedJan 20, 16May 19, 16[C07D]
2016/0047,812 METHOD FOR DETECTING COLON CANCERAbandonedMar 19, 14Feb 18, 16[G01N]
2016/0002,247 8-SUBSTITUTED IMIDAZOPYRIMIDINONE DERIVATIVE HAVING AUTOTAXIN INHIBITORY ACTIVITYAbandonedFeb 27, 14Jan 07, 16[C07D]
2015/0344,502 CEPHEM COMPOUNDAbandonedDec 26, 13Dec 03, 15[C07D]
2015/0337,002 NUCLEOSIDE AND NUCLEOTIDE HAVING SULFONAMIDE STRUCTUREAbandonedJan 14, 14Nov 26, 15[C07H]
2015/0246,938 NOVEL OLEFIN DERIVATIVEAbandonedSep 07, 12Sep 03, 15[C07F, C07D]
2015/0148,385 PHARMACEUTICAL COMPOSITION CONTAINING A COMPOUND HAVING A THROMBOPOIETIN RECEPTOR AGONISTIC ACTIVITYAbandonedJun 28, 13May 28, 15[A61K]
2015/0057,447 METHOD OF PRODUCING N-PHENYL-N'-PHENYLSULFONYL PIPERAZINE DERIVATIVE AND INTERMEDIATE THEREOFAbandonedMar 29, 13Feb 26, 15[C07D]
2014/0323,722 OXADIAZOLE DERIVATIVE HAVING ENDOTHELIAL LIPASE INHIBITORY ACTIVITYAbandonedApr 29, 14Oct 30, 14[C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.